Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abpro Holdings Inc (ABP)

Abpro Holdings Inc (ABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,418
  • Shares Outstanding, K 2,716
  • Annual Sales, $ 180 K
  • Annual Income, $ -7,230 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 0.00
  • Price/Sales 7.88
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.23
  • Most Recent Earnings $-0.63 on 11/14/25
  • Next Earnings Date 04/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5171 +0.95%
on 02/20/26
3.3271 -84.31%
on 01/22/26
-2.5680 (-83.11%)
since 01/20/26
3-Month
0.5171 +0.95%
on 02/20/26
7.3400 -92.89%
on 11/24/25
-5.8480 (-91.81%)
since 11/20/25
52-Week
0.5171 +0.95%
on 02/20/26
29.9700 -98.26%
on 02/21/25
-27.6780 (-98.15%)
since 02/20/25

Most Recent Stories

More News
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid tumors, today...

ABP : 0.5220 (-34.76%)
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72

FDA clearance enables initiation of Abpro’s first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro’s global collaboration with...

ABP : 0.5220 (-34.76%)
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers

 IND submitted for ABP-102/CT-P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable safety profile ABP-102/CT-P72 represents...

ABP : 0.5220 (-34.76%)
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives

BURLINGTON, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP) (“Abpro” or the “Company”), a biotechnology company advancing next-generation antibody therapies, today...

ABP : 0.5220 (-34.76%)
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager

CT-P72/ABP-102 poster selected as one of the Top 150 abstracts out of more than 1,300 submissions at SITC 2025  CT-P72/ABP-102 demonstrates potent and selective anti-tumor activity in HER2-high models,...

ABP : 0.5220 (-34.76%)
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025

Achieved ~60% reduction in operating costs through a focused cost optimization plan DiversImmune ® platform positioned to unlock additional pipeline value Reverse stock split supports Nasdaq...

ABP : 0.5220 (-34.76%)
Abpro Holdings Approves Reverse Stock Split

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Abpro Holdings...

ABP : 0.5220 (-34.76%)
Abpro Holdings Appeals Nasdaq Delisting Notice

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

ABP : 0.5220 (-34.76%)
Abpro Holdings Furloughs Chief Medical Officer

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Abpro Holdings...

ABP : 0.5220 (-34.76%)
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

ABP : 0.5220 (-34.76%)

Business Summary

Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

See More

Key Turning Points

3rd Resistance Point 0.9580
2nd Resistance Point 0.8689
1st Resistance Point 0.6954
Last Price 0.5220
1st Support Level 0.4328
2nd Support Level 0.3437
3rd Support Level 0.1702

See More

52-Week High 29.9700
Fibonacci 61.8% 18.7190
Fibonacci 50% 15.2436
Fibonacci 38.2% 11.7681
Last Price 0.5220
52-Week Low 0.5171

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar